Armistice Capital, LLC 13D/13G Filings for BioXcel Therapeutics, Inc. (BTAI)

Armistice Capital, LLC 13D and 13G filings for BioXcel Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-05-15
3:33 pm
Sale		 2025-03-31 13G BioXcel Therapeutics, Inc.
BTAI		 Armistice Capital, LLC 288,131
4.990%		 -4,709,144decrease
(-94.23%)		 Filing
2025-02-14
5:27 pm
Purchase		 2024-12-31 13G BioXcel Therapeutics, Inc.
BTAI		 Armistice Capital, LLC 4,997,275
9.990%		 4,997,275increase
(New Position)		 Filing